Morgan Stanley’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36.9M Buy
1,118,080
+106,335
+11% +$3.51M ﹤0.01% 2199
2025
Q1
$40.7M Sell
1,011,745
-241,243
-19% -$9.7M ﹤0.01% 2002
2024
Q4
$58.9M Buy
1,252,988
+84,616
+7% +$3.98M ﹤0.01% 1690
2024
Q3
$61.7M Buy
1,168,372
+62,698
+6% +$3.31M ﹤0.01% 1638
2024
Q2
$59.9M Buy
1,105,674
+150,816
+16% +$8.17M ﹤0.01% 1584
2024
Q1
$66.9M Sell
954,858
-3,848,306
-80% -$270M 0.01% 1495
2023
Q4
$401M Buy
4,803,164
+3,750,958
+356% +$313M 0.02% 766
2023
Q3
$31M Buy
1,052,206
+143,955
+16% +$4.24M ﹤0.01% 2020
2023
Q2
$29.6M Buy
908,251
+96,007
+12% +$3.13M ﹤0.01% 2079
2023
Q1
$28.6M Sell
812,244
-453,618
-36% -$16M ﹤0.01% 2057
2022
Q4
$58M Sell
1,265,862
-144,504
-10% -$6.62M 0.01% 1380
2022
Q3
$68.3M Sell
1,410,366
-89,739
-6% -$4.35M 0.01% 1116
2022
Q2
$58.9M Buy
1,500,105
+329,286
+28% +$12.9M 0.01% 1259
2022
Q1
$43.1M Buy
1,170,819
+299,157
+34% +$11M 0.01% 1401
2021
Q4
$39.7M Buy
871,662
+30,738
+4% +$1.4M ﹤0.01% 1515
2021
Q3
$30.1M Sell
840,924
-89,036
-10% -$3.18M ﹤0.01% 1693
2021
Q2
$18.4M Buy
929,960
+226,743
+32% +$4.49M ﹤0.01% 2249
2021
Q1
$16.4M Sell
703,217
-191,460
-21% -$4.45M ﹤0.01% 2134
2020
Q4
$18.6M Buy
894,677
+53,600
+6% +$1.11M ﹤0.01% 1876
2020
Q3
$18.2M Buy
841,077
+136,290
+19% +$2.95M ﹤0.01% 1552
2020
Q2
$16.6M Sell
704,787
-256,868
-27% -$6.05M ﹤0.01% 1546
2020
Q1
$11.3M Sell
961,655
-404,873
-30% -$4.77M ﹤0.01% 1670
2019
Q4
$14.5M Buy
1,366,528
+1,090,420
+395% +$11.6M ﹤0.01% 1981
2019
Q3
$3.14M Sell
276,108
-10,128
-4% -$115K ﹤0.01% 3370
2019
Q2
$3.22M Buy
286,236
+196,786
+220% +$2.21M ﹤0.01% 3358
2019
Q1
$724K Sell
89,450
-78,204
-47% -$633K ﹤0.01% 4325
2018
Q4
$1.06M Buy
167,654
+23,310
+16% +$147K ﹤0.01% 4236
2018
Q3
$1.42M Sell
144,344
-86,980
-38% -$857K ﹤0.01% 4264
2018
Q2
$1.92M Buy
231,324
+90,265
+64% +$749K ﹤0.01% 4111
2018
Q1
$1.02M Sell
141,059
-24,098
-15% -$173K ﹤0.01% 4531
2017
Q4
$1.35M Sell
165,157
-63,015
-28% -$513K ﹤0.01% 4346
2017
Q3
$3.31M Sell
228,172
-65,058
-22% -$943K ﹤0.01% 3391
2017
Q2
$3.55M Buy
293,230
+10,919
+4% +$132K ﹤0.01% 3248
2017
Q1
$3.63M Buy
282,311
+67,029
+31% +$861K ﹤0.01% 3214
2016
Q4
$2.62M Buy
215,282
+161,644
+301% +$1.96M ﹤0.01% 3677
2016
Q3
$493K Buy
53,638
+45,995
+602% +$423K ﹤0.01% 4531
2016
Q2
$73K Sell
7,643
-1,848
-19% -$17.7K ﹤0.01% 5385
2016
Q1
$67K Sell
9,491
-112,155
-92% -$792K ﹤0.01% 5493
2015
Q4
$1.27M Sell
121,646
-727,832
-86% -$7.61M ﹤0.01% 3875
2015
Q3
$5.68M Buy
849,478
+474,290
+126% +$3.17M ﹤0.01% 2541
2015
Q2
$2.52M Buy
375,188
+16,491
+5% +$111K ﹤0.01% 3408
2015
Q1
$2.43M Buy
358,697
+254,683
+245% +$1.73M ﹤0.01% 3413
2014
Q4
$833K Sell
104,014
-158,136
-60% -$1.27M ﹤0.01% 4298
2014
Q3
$923K Sell
262,150
-176,629
-40% -$622K ﹤0.01% 4101
2014
Q2
$2.1M Buy
438,779
+202,204
+85% +$967K ﹤0.01% 3447
2014
Q1
$2.25M Buy
236,575
+65,913
+39% +$626K ﹤0.01% 3313
2013
Q4
$1.11M Sell
170,662
-122,059
-42% -$793K ﹤0.01% 3857
2013
Q3
$2.22M Buy
+292,721
New +$2.22M ﹤0.01% 3136